Business Description
AdAlta Ltd
ISIN : AU0000001AD2
Total Employee Number:
1Description
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation cells and protein based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.22 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45 | |||||
3-Year EPS without NRI Growth Rate | 46.4 | |||||
3-Year FCF Growth Rate | 47.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.27 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -89.6 | |||||
Shareholder Yield % | -54.48 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -245.97 | |||||
ROIC % | -919.14 | |||||
3-Year ROIIC % | -110.66 | |||||
ROC (Joel Greenblatt) % | -2072.17 | |||||
ROCE % | -1377.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -2.3 | |||||
EV-to-EBITDA | -2.3 | |||||
EV-to-Forward-Revenue | 5.57 | |||||
EV-to-FCF | -2.27 | |||||
Earnings Yield (Greenblatt) % | -43.48 | |||||
FCF Yield % | -46.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AdAlta Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.003 | ||
| Beta | 0.9652 | ||
| 3-Year Sharpe Ratio | -0.24 | ||
| 3-Year Sortino Ratio | -0.36 | ||
| Volatility % | 139.32 | ||
| 14-Day RSI | 44.88 | ||
| 14-Day ATR (A$) | 0.000513 | ||
| 20-Day SMA (A$) | 0.00335 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (A$) | 0.002 - 0.008 | ||
| Shares Outstanding (Mil) | 3,212.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AdAlta Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AdAlta Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2025-12-09 | 0.00 (+0.00%) |
Show
Entries
AdAlta Ltd Frequently Asked Questions
What is AdAlta Ltd(ASX:1AD)'s stock price today?
The current price of ASX:1AD is A$0.00. The 52 week high of ASX:1AD is A$0.01 and 52 week low is A$0.00.
When is next earnings date of AdAlta Ltd(ASX:1AD)?
The next earnings date of AdAlta Ltd(ASX:1AD) is .
Does AdAlta Ltd(ASX:1AD) pay dividends? If so, how much?
AdAlta Ltd(ASX:1AD) does not pay dividend.
Press Release
Articles on AdAlta Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers